PHARMALIDER
PHARMALIDER, a prominent player in the pharmaceutical industry, is headquartered in Mexico (MX) and operates extensively across Latin America. Founded in 2005, the company has established itself as a leader in the development and manufacturing of high-quality pharmaceutical products, including generics and over-the-counter medications. With a commitment to innovation and excellence, PHARMALIDER offers a diverse portfolio that caters to various therapeutic areas, setting itself apart through rigorous quality control and adherence to international standards. The company has achieved significant milestones, including numerous certifications that underscore its market position. Recognised for its dedication to improving healthcare outcomes, PHARMALIDER continues to expand its reach, making a substantial impact in the pharmaceutical landscape of the region.
DitchCarbon Score
How does PHARMALIDER's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PHARMALIDER's score of 0 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
PHARMALIDER's reported carbon emissions
PHARMALIDER, headquartered in Mexico (MX), currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from PHARMALIDER, it is unclear what their particular commitments or initiatives may be.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PHARMALIDER is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
